NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

人工生命內臟器官及醫療生物工學市場,各類型(人工生命內臟器官,醫療生物工學)及地區別-尺寸,佔有率,預測,及機會分析,2020∼2027

Artificial Vital Organs and Medical Bionics Market, By Type (Artificial Vital Organs, Medical Bionics ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 942052
出版日期 內容資訊 英文 181 Pages
商品交期: 2-3個工作天內
價格
人工生命內臟器官及醫療生物工學市場,各類型(人工生命內臟器官,醫療生物工學)及地區別-尺寸,佔有率,預測,及機會分析,2020∼2027 Artificial Vital Organs and Medical Bionics Market, By Type (Artificial Vital Organs, Medical Bionics ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年06月05日內容資訊: 英文 181 Pages
簡介

本報告提供全球人工重要內臟器官與醫學生物工學市場調查,提供市場力學,法規,趨勢分析,各類型,各地區的分析,競爭情形等資訊。

目錄

第1章 調查的目的與前提

第2章 市場展望

  • 報告概要
  • 市場定義和範圍
  • 摘要整理
  • 各類型市場
  • 連貫機遇地圖(COM)

第3章 市場力學,法規,趨勢分析

  • 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
  • 影響分析
  • 主要的動向
  • 技術的進步
  • 法規方案

第4章 市場分析:各類型

  • 簡介
  • 市場佔有率分析:2019年和2027年
  • 與前一年同期比較成長率分析:2019年-2027年
  • 市場區隔趨勢
  • 人工重要內臟器官
    • 人工心臟
    • 人工腎臟
    • 人工肝臟
    • 人工胰臟
    • 人工肺
  • 醫學生物工學
    • 人工電子耳
    • 人工視覺
    • 外骨骼
    • 人工義肢
    • 腦仿生
    • 心臟仿生

第5章 市場分析:各地區

  • 簡介
  • 市場佔有率分析:2019年和2027年
  • 與前一年同期比較成長率分析:2019年-2027年
  • 市場區隔趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東
    • GCC加盟國
    • 以色列
    • 其他
  • 非洲
    • 北非
    • 中非
    • 南非

第6章 競爭情形

  • 企業簡介
    • 公司概要
    • 產品系列
    • 主要的動向
    • 財務實際成果
    • 策略
  • BiVACOR
  • CARMAT
  • Cleveland Heart
  • Jarvik Heart
  • MyLVAD
  • Cirtec Medical Systems
  • Thoratec Corporation
  • Abbott Diabetes Care, Inc.
  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Cyberonics, Inc.
  • Edwards Lifesciences Corporation
  • 其他企業

第7章

  • 參考文獻
  • 調查手法
目錄

Title:
Artificial Vital Organs and Medical Bionics Market, By Type (Artificial Vital Organs (Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs), Medical Bionics (Cochlear Implants, Vision Bionics, Exoskeletons, Bionic Limbs, Brain Bionics, Cardiac Bionics)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Artificial Vital Organs are man-made devices that are created to work like original diseases organ or to restore a specific function of that organ. These devices are implanted at the site of the diseased organ in the patient. Medical bionics is the study of application of mechanics and electronics for the replacement of a limb or other part of a functional organ that is mechanically powered. Artificial organs can be an artificial heart, artificial kidney, artificial pancreas and others. An artificial organ consists of different parts that mimic functions of the original organ. For instance, artificial pancreas systems comprise of devices that are already used in diabetes management such as Continuous glucose monitoring (CGM) device, insulin pump, blood glucose device (BGD), and digital control device with control algorithm. Artificial pancreas systems are compatible with existing pumps and CGMs and its control functions can be integrated into a regular smartphone.

Restraints of the Global Artificial Vital Organs and Medical Bionics Market

Major factors hampering the growth of the Artificial Vital Organs and Medical Bionics market during the forecast period constitutes of criticism associated with artificial organ transplant, and high costs.

Key features of the study:

  • This report provides in-depth analysis of the global Artificial Vital Organs and Medical Bionics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global Artificial Vital Organs and Medical Bionics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include SynCardia Systems, LLC, BiVACOR, CARMAT, Cleveland Heart, Jarvik Heart, MyLVAD, Cirtec Medical Systems, Thoratec Corporation, Abbott Diabetes Care, Inc., Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Cyberonics, Inc., Edwards Lifesciences Corporation, Ekso Bionics Holdings, Inc., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Gambro AB (Baxter International, Inc.), and iWalk, Inc.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Artificial Vital Organs and Medical Bionics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Artificial Vital Organs and Medical Bionics Market, By Type:
  • Artificial Vital Organs
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs
  • Medical Bionics
  • Cochlear Implants
  • Vision Bionics
  • Exoskeletons
  • Bionic Limbs
  • Brain Bionics
  • Cardiac Bionics
  • Global Artificial Vital Organs and Medical Bionics Market, By Geography:
  • North America
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Type
  • Artificial Vital Organs
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
  • Medical Bionics
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics
  • By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • SynCardia Systems, LLC*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • BiVACOR
  • CARMAT
  • Cleveland Heart
  • Jarvik Heart
  • MyLVAD
  • Cirtec Medical Systems
  • Thoratec Corporation
  • Abbott Diabetes Care, Inc.
  • Abiomed, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Cyberonics, Inc.
  • Edwards Lifesciences Corporation
  • Other Major Players

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Type
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario

4. Global Artificial Vital Organs and Medical Bionics Market, By Type, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Artificial Vital Organs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Artificial Heart
    • Artificial Kidney
    • Artificial Liver
    • Artificial Pancreas
    • Artificial Lungs
    • Medical Bionics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Cochlear Implants
    • Vision Bionics
    • Exoskeletons
    • Bionic Limbs
    • Brain Bionics
    • Cardiac Bionics

5. Global Artificial Vital Organs and Medical Bionics Market, By Regions, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

    • Company Profiles
    • SynCardia Systems, LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • BiVACOR
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • CARMAT
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cleveland Heart
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Jarvik Heart
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • MyLVAD
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cirtec Medical Systems
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Thoratec Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abbott Diabetes Care, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abiomed, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Asahi Kasei Medical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cyberonics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Edwards Lifesciences Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Other Major Players
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

7. Section

    • References
    • Research Methodology
    • About us and Sales Contact